Student name
Course
Professor
Date
Dopamine and Psychiatric Disorders
1
2
Dopamine and Psychiatric Disorders
Introduction
One chemical messenger that functions in the brain is dopamine. Nerve cells use it to
communicate with one another. It affects cells in different brain areas and is produced by deep
brain cells. Dopamine also controls mood, locomotion, sleep, memory, and learning (Martel et
al., 2020). Dopamine levels in the brain rise when you experience positive emotions, such as
when you succeed or enjoy yourself. Dopamine plays a role in addiction; at times, you may find
yourself desiring more of this dopamine "reward."
Dopamine in the brain
The brain's substantia ventral tegmental region, hypothalamus, and nigra are the locations
where dopamine is created (Freudenmacher et al., 2020). Dysfunction of the dopamine system
has been connected to several neurological conditions. Any reward or a lot of highly addictive
medications causes the level of dopamine transmission to increase. Dopamine affects brain
regions that are involved in motivation, pleasure, and satisfaction.
Dopamine pathways and receptors
The brain comprises four main dopaminergic routes: the tuberoinfundibular, mesolimbic,
mesocortical, and nigrostriatal pathways. The dorsal striatum receives axons from dopaminergic
neurons arising in the substantia nigra, which mediate the coordination of voluntary movements.
Dopamine binds to two types of receptors: D2 and D1-like. D1-like receptors stimulate adenylate
cyclase to increase cyclic AMP, but D2-like receptors are known to decrease adenylate cyclase
(Kaur et al., 2020). The interaction of these receptors affects the many physiological effects of
dopamine in various brain areas, supporting processes including emotional regulation, reward
processing, and motor coordination. The significance of balanced dopaminergic
3
neurotransmission in preserving mental health is highlighted by the involvement of dysregulation
in these pathways and receptor activity in several psychiatric illnesses.
Dopamine and psychiatric disorders
Dopamine is involved in mental illnesses in a significant way. A considerable portion of
dopamine's function is to regulate the relationship between the brain's frontal lobe, which
governs an individual's purposeful and goal-oriented behaviour, and the retrograde brain regions.
Dopamine is thought to play a vital role in the development of the mechanisms behind
alcoholism, gambling addiction, and internet/computer addiction since it is intimately linked to
an individual's propensity to persist in a given behaviour or habit.
Parkinson's disease
Dopamine levels are deficient in Parkinson's disease patients. Parkinson's disease signs
and symptoms will start to appear as the dopamine levels begin to drop. This implies that
symptoms like shaking or limb stiffness may take the place of the fluid, regulated motions of the
body. Dopamine levels in the striatum are subsequently low as a result, which causes stiffness,
bradykinesia, tremors, and other motor symptoms (Latif et al., 2021). Movement and
coordination are not regulated properly due to an imbalance in the nigrostriatal system. Even if
drugs like levodopa try to raise dopamine levels, the underlying deterioration is not stopped by
them. Deep brain stimulation and other state-of-the-art treatments aim to target specific brain
regions.
Schizophrenia
A severe psychiatric disease called schizophrenia is closely associated with the
dysregulation of dopamine. The mesolimbic pathway's excessive dopamine transmission has
been linked to schizophrenia's positive symptoms, such as delusions and hallucinations (Martel
ADHD
A further psychiatric disorder associated with dopamine impairment, namely in the
prefrontal cortex, is Attention Deficit Hyperactivity Disorder (ADHD). Working memory,
impulse control, and attention are examples of executive activities for which the prefrontal cortex
is essential. These cognitive processes are modulated by dopamine via D1 receptors (Perugi et
al., 2022). Dopamine transmission in the prefrontal cortex appears to be compromised in ADHD,
which may account for the disorder's hallmark symptoms of impulsivity, hyperactivity, and
inattention. Stimulant drugs, such as amphetamine and methylphenidate, are frequently used to
treat ADHD because they raise dopamine levels in synapses, which improves signalling and
cognitive abilities.
Contribution to Addiction
Dopamine is essential to addiction because it powers the reward system in the brain.
Dopamine is elevated during substance usage or addictive behaviours, which strengthens the link
between addictive stimuli and pleasure. The addictive behaviour is encouraged to be repeated as
a result of this increased release. Long-term exposure causes the brain to adjust, lowering
baseline dopamine levels and increasing tolerance and cravings. Addiction's onset and
persistence are facilitated by dopamine dysregulation (Wise et al.,2020). Comprehending the
complex interactions between dopamine and the reward system sheds light on how addictive
4
et al., 2020). The delicate balance is upset by this hyperactivity, which also adds to the disorder's
distorted perceptions and thinking. The goal of antipsychotic drugs, which frequently block D2
receptors, is to restore neurotransmitter balance and alleviate symptoms by bringing dopamine
levels in the mesolimbic pathway back to normal.
5
behaviours are reinforced. It guides treatment approaches designed to bring the dopamine system
back into balance and promote addiction recovery.
Dopamine and mood disorders
Dopamine deficiency has also been linked to mood disorders such as bipolar disorder and
major depressive disorder (MDD). There is evidence that depression is accompanied by
decreased dopamine activity in specific brain regions, which may contribute to symptoms like
low motivation and anhedonia. Conversely, high dopamine levels are linked to the manic phase
of bipolar illness. Dopamine's sensitive role in mood modulation emphasizes its importance in
preserving emotional balance (Radwan et al., 2019). Dopamine activity is shown to be elevated
during manic episodes, but dopamine levels are inversely correlated with depressed episodes.
Lithium and other antipsychotic drugs are examples of mood stabilizers that are frequently used
to treat bipolar disorder. These drugs may work in part by modifying dopamine
neurotransmission.
Impact of dopamine imbalance
While dopamine deficiency is associated with mood and motor disorders, excess
dopamine transmission has been connected to the development of psychotic illnesses. These
illnesses arise due to complex interactions between environmental influences and genetic
predisposition. Stressors and genetic susceptibility, for example, can cause schizophrenia,
highlighting the complex interplay between several factors that contribute to mental health
disorders (Conio et al., 2020). The delicate balance necessary for normal brain function is upset
by neurotransmitter abnormalities, which emphasizes the need for all-encompassing approaches
to the diagnosis, treatment, and management of mental illnesses.
Conclusion
6
To sum up, dopamine is a complex neurotransmitter with broad ramifications for mental
health issues. Its complicated significance in sustaining mental health is highlighted by its
distribution in critical brain regions, involvement in various neuronal pathways, and contact with
specific receptors. Dopamine imbalances play a role in the pathogenesis of multiple mental
illnesses, such as bipolar disorder, ADHD, Parkinson's disease, and schizophrenia (Chanda et al.,
2019). Comprehending the intricate interactions between dopamine in various ailments is crucial
for creating focused treatment plans and enhancing the lives of those impacted by these illnesses.
Research on the complex network of dopamine activity in the brain is still ongoing, and it could
lead to improvements in mental treatment in the future.
7
References
Chanda, C., & Surepalli, S. (2019). Dopaminergic dysfunction in neuropsychiatric disorders.
Pathophysiology, current therapeutics, and future perspectives.Neuropsychiatria i
Neuropsychologia/Neuropsychiatry and Neuropsychology,14(1), 39-47.
Conio, B., Martino, M., Magioncalda, P., Escelsior, A., Inglese, M., Amore, M., & Northoff, G.
(2020). Opposite effects of dopamine and serotonin on resting-state networks: review and
implications for psychiatric disorders.Molecular Psychiatry,25(1), 82-93.
Freudenmacher, L., Schauer, M., Walkowiak, W., & von Twickel, A. (2020). Refinement of the
dopaminergic system of anuran amphibians based on connectivity with habenula, basal
ganglia, limbic system, pallium, and spinal cord.Journal of Comparative
Neurology,528(6), 972-988.
Kaur, S., Singh, S., Jaiswal, G., Kumar, S., Hourani, W., Gorain, B., & Kumar, P. (2020).
Pharmacology of dopamine and its receptors.Frontiers in Pharmacology of
Neurotransmitters, 143-182.
Latif, S., Jahangeer, M., Razia, D. M., Ashiq, M., Ghaffar, A., Akram, M., ... & Ansari, M. A.
(2021). Dopamine in Parkinson's disease.Clinica chimica acta,522, 114-126.
8
Martel, J. C., & Gatti McArthur, S. (2020). Dopamine receptor subtypes, physiology, and
pharmacology: new ligands and concepts in schizophrenia.Frontiers in
pharmacology,11, 1003.
Perugi, G., De Rosa, U., & Barbuti, M. (2022). What value do norepinephrine/dopamine dual
reuptake inhibitors have to the current treatment of adult attention deficit hyperactivity
disorder (ADHD) treatment armamentarium?Expert Opinion on
Pharmacotherapy,23(18), 1975-1978.
Radwan, B., Liu, H., & Chaudhury, D. (2019). The role of dopamine in mood disorders and the
associated changes in circadian rhythms and sleep-wake cycle.Brain Research,1713, 42-
51.
Wise, R. A., & Robble, M. A. (2020). Dopamine and addiction.Annual review of
psychology,71, 79-106.
